Wirestock/iStock Editorial via Getty Images
- The U.S. FDA has approved GSK’s (NYSE:GSK
) Blujepa (gepotidacin), a topoisomerase inhibitor antibiotic for uncomplicated urinary tract infections.
- The indication is for females 12 years and older weighing at least 40kg.
- The recommended dosage is 1,500 mg (two 750 mg tablets) taken
https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1442119524/image_1442119524.jpg?io=getty-c-w750
2025-03-25 17:02:04
